Skip to main content
. Author manuscript; available in PMC: 2018 Feb 14.
Published in final edited form as: Breast Cancer Res Treat. 2016 Dec 22;161(3):567–574. doi: 10.1007/s10549-016-4083-6

Table 2.

Threshold discriminatory value: comparison between endoxifen threshold and AAS threshold

Amount of patients (% of 1370)
Endoxifen ≥ 5.97 ng/mL Endoxifen <5.97 ng/mL
AAS ≥ 1798 1083 (79.1) 48 (3.5)
AAS < 1798 24 (1.7) 215 (15.7)

AAS Antiestrogenic Activity Score; 5.97 ng/mL